We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Expert Panel Recommends Five Drugs, Endorses Celltrion’s Regdanvimab for COVID-19
EMA Expert Panel Recommends Five Drugs, Endorses Celltrion’s Regdanvimab for COVID-19
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended five medicines for approval at its monthly meeting last week — and issued a positive review of Celltrion’s monoclonal antibody, regdanvimab, for treatment of COVID-19.